Video

Dr. Weigert on Cancer Screening for Women With Dense Breasts

Jean Weigert, MD,the head of breast imaging for the Hospital of Central Connecticut, discusses the importance of increased breast cancer screening for women with high breast tissue density. After Connecticut became the first state to mandate that patients be informed of their breast tissue density and recommended the appropriate supplemental imaging, Weigert gathered four years of data to determine the impact of this additional imaging.

She found that for women with breast tissue density higher than 50%, regular ultrasounds resulted in nearly twice as many identified breast cancers, compared to mammography alone. Many of these cancers were small or node-negative, and may not have been identified until they progressed further if not for the supplemental imaging.

This data changes the paradigm of how women should be screened for breast cancer, says Weigert. Patients should be broken down into risk groups, and given recommendations on screening based on those groups. Low-risk women should have a mammogram every year, high-risk women with strong family history should have a mammogram plus an MRI, and women with no significant family history but with high breast tissue density should have an ultrasound as part of their routine screening every year.

<<<

View more from the 2014 San Antonio Breast Cancer Symposium

Related Videos
Jacob Sands, MD, oncology medical director, International Patient Center, Dana-Farber Cancer Institute; assistant professor, Harvard Medical School
Fred R. Hirsch, MD, PhD, executive director, Center for Thoracic Oncology, The Tisch Cancer Institute at Mount Sinai; Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Alastair Thompson, BSc, MBChB, MD, FRCS
Adam M. Brufsky, MD, PhD, FACP
Sara M. Tolaney, MD, MPH
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Chirag Shah, MD